4/A//SEC Filing
Centea Scott 4/A
Accession 0001567619-21-022711
CIK 0001275187other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 5:57 PM ET
Size
8.7 KB
Accession
0001567619-21-022711
Insider Transaction Report
Form 4/AAmended
Centea Scott
SVP/GM, VIT
Transactions
- Award
Performance Right
2021-07-21+5,684→ 5,684 total→ Common Stock (5,684 underlying) - Award
Non-Qualified Stock Option (right to buy)
2021-07-21+7,721→ 7,721 totalExercise: $26.49From: 2022-07-21Exp: 2031-07-21→ Common Stock (7,721 underlying)
Footnotes (3)
- [F1]On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of performance rights and stock options of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance rights and the exercise price of the options.
- [F2]Each performance right represents a contingent right to receive one share of common stock of the Company ("Common Stock"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.
- [F3]These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001823973
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 5:57 PM ET
- Size
- 8.7 KB